Company profile: Tjoapack
1.1 - Company Overview
Company description
- Provider of contract pharmaceutical packaging services, offering innovative primary and secondary packaging for oral solid doses (blister packs, wallets, bottles) and injectables (pre-filled syringes, vials, ampoules); unit-dose solutions with barcode verification; custom blister design, foil printing and high-speed packaging; bottle packaging with tamper-proof and child-resistant features; handling small and large-scale batches.
Products and services
- Oral Solid Dosage Packaging: Delivers primary and secondary packaging for oral solids into blister packs, wallets, and bottles, handling small- and large-scale batches with flexibility to meet varying volume requirements
- Contract Pharmaceutical Packaging: Supplies tailored primary and secondary packaging for medicines using automated processes, leveraging 19 packaging lines to ensure safe delivery for clients across five continents and 45 countries
- Unit Dose Packaging: Architects barcode-verified unit-dose packaging for hospital pharmacies, enhancing medication management and patient safety with barcode verification integrated into each unit
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Tjoapack
Asymchem
HQ: China
Website
- Description: Provider of CDMO and pharmaceutical manufacturing services and biotech solutions, focused on R&D of pharmaceutical raw materials synthesis technology applied to drug development and production, supporting efficient, flexible processes and accelerating the commercial launch of biotech products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Asymchem company profile →
Enavate Sciences
HQ: United States
Website
- Description: Provider of capital and strategic growth support to therapeutic and enabling technology companies, partnering with life sciences companies and their investors to advance and accelerate the development of novel therapies and help companies realize their potential.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enavate Sciences company profile →
ProSciento
HQ: United States
Website
- Description: Provider of clinical research and development services, leveraging broad scientific expertise, direct patient access, advanced methodologies, and integrated operations to advance science and achieve quality results through client and partner connections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProSciento company profile →
Florida Pharma Products
HQ: United States
Website
- Description: Provider of generic prescription pharmaceuticals, covering development, sales, marketing, and distribution across therapeutic areas. Also provides R&D to identify new treatments, project management from R&D to commercialization, business development via licensing, acquisition, profit-sharing and development partnerships, plus operations to reduce costs and increase productivity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Florida Pharma Products company profile →
Reaction Biology
HQ: United States
Website
- Description: Provider of assay services and protein production for early-stage drug discovery, including biochemical, biophysical, electrophysiological and cell assays for high throughput screening (HTS); kinase and epigenetic assays; recombinant and custom protein production; 2D/3D cell-based assays; in vivo pharmacology (xenograft, immuno-oncology tumor models); and ADME & safety with in vitro safety screening, cardiac safety assessment, and in vivo PK/PD studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Reaction Biology company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Tjoapack
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Tjoapack
2.2 - Growth funds investing in similar companies to Tjoapack
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Tjoapack
4.2 - Public trading comparable groups for Tjoapack
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →